XML 45 R31.htm IDEA: XBRL DOCUMENT v3.24.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense Benefit

The following table presents the income (loss) before income taxes for domestic and foreign operations, and the components of the provision (benefit) for income taxes for the years ended December 31:

 

   2023   2022 
Domestic loss  $(425)  $(13,885)
Foreign subsidiaries income (loss)   709    (18)
Income (loss) before income taxes  $284   $(13,903)

 

   2023   2022 
Current income tax expense:          
Federal  $2   $— 
State   56    21 
Foreign   250    306 
Total Current   308    327 
           
Deferred income tax expense (benefit):          
Federal   —    — 
State   —    — 
Foreign   66    (143)
Total Deferred   66    (143)
Total provision for income taxes  $374   $184 
Schedule of Effective Income Tax

The Company’s effective tax rate differs from the federal statutory rate due to the following for the years ended December 31:

 

   2023   2022 
Statutory federal income tax rate   21.00%   21.00%
State income taxes, net of federal tax benefits   23.20%   1.00%
Stock compensation   84.92%   -1.43%
ASC 842 Adoption   0.00%   1.48%
Foreign rate differential   58.55%   -1.20%
GILTI Inclusion   26.15%   -0.17%
Non-deductible expenses   1.02%   0.00%
Valuation allowance   -83.07%   -22.00%
Effective tax rate   131.77%   -1.32%
Schedule of Components of the Company’s Deferred Tax Assets and Liabilities

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table presents the significant components of the Company’s deferred tax assets and liabilities at December 31:

 

   2023   2022 
Gross deferred tax assets:          
Net operating loss carryforward  $18,887   $18,937 
Section 174 capitalized costs   1,873    1,697 
Tax credits   100    99 
Accruals and reserves   1,927    2,314 
Property and equipment   21    51 
ASC 842   12    14 
Alternative minimum tax credits   21    21 
Total gross deferred tax assets   22,841    23,133 
Less: valuation allowance   (22,774)   (22,996)
Total deferred tax assets net of valuation allowance   67    137 
Deferred tax liabilities:          
ASC 842 right of use asset   (12)   (14)
Net deferred tax assets  $55   $123 
Schedule of Cumulative Foreign Earnings

Estimate of cumulative foreign earnings is as follows as of December 31:

 

   2023   2022 
China  $5,471   $5,031 
India   5,102    5,098 
Total  $10,573   $10,129 
Summary of Operating Loss Carryforwards

The Company had net operating loss carryovers as follows as of December 31:

 

   2023   2022 
Federal NOL  $88,066   $88,375 
Domestic Tax Authority  $88,066   $88,375 
State NOL  $7,086   $7,429 
State and Local Jurisdiction  $7,086   $7,429 
Summary of Tax Credit Carryforwards

The Company had research and development (“R&D”) credit carryforwards as follows as of December 31:

 

   2023   2022 
Federal R&D credits  $—   $— 
Internal Revenue Service (IRS)  $—   $— 
California R&D credits  $127   $125 
California Franchise Tax Board  $127   $125 
Schedule of Unrecognized Tax Benefits

The following table summarizes the activity related to unrecognized tax benefits as follows as of December 31:

 

   2023   2022 
Unrecognized benefit-beginning of period  $1,273   $1,306 
Gross increases-prior period tax positions   1    — 
Gross (decreases)-prior period tax positions   —    (33)
Unrecognized benefit-end of period  $1,274   $1,273